Derrick Zhang

Derrick Zhang is a Senior Scientist II at the United States Pharmacopeia (USP), where he leads the development of strategies and standards supporting the analytical evaluation of monoclonal antibodies (mAbs) and therapeutic proteins, with deep expertise in Host Cell Protein (HCP) analysis and LC-MS proteomics. He brings over a decade of biopharmaceutical experience spanning process development, analytical characterization, and method development across organizations including Adaptive Phage Therapeutics, United Therapeutics, and Meso Scale Diagnostics.